Effects of Phosphodiesterase Inhibitors on Cytokine Production
Author Information
Author(s): K. L. Molnar-Kimber, A. L. Yonno, R. J. Heaslip, B. M. Weichman
Primary Institution: Wyeth-Ayerst Research
Hypothesis
The study investigates how selective phosphodiesterase inhibitors affect TNF-α and IL-1β production from LPS-stimulated human monocytes.
Conclusion
PDE-IV inhibitors can significantly suppress TNF-α production, while PDE-V inhibitors may augment it.
Supporting Evidence
- PDE-IV inhibitors caused a concentration-dependent inhibition of TNF-α production.
- PDE-III inhibitors weakly inhibited TNF-α but had no effect on IL-1β production.
- PDE-V inhibition was associated with an increase in cytokine secretion.
- Rolipram and nitraquazone suppressed IL-1β secretion from LPS-stimulated human monocytes.
Takeaway
Some medicines can help control how much of certain substances our body makes when it gets sick, which can help with diseases like arthritis.
Methodology
The study used human monocytes isolated from healthy males and measured cytokine production after treatment with various phosphodiesterase inhibitors.
Limitations
Variability in sensitivity of IL-1β production to PDE-IV inhibitors between donor monocyte preparations.
Participant Demographics
Healthy Caucasian males
Statistical Information
P-Value
0.004
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website